The Layton Center currently has clinical trials for people with mild cognitive impairment, early stage Alzheimer's disease and those without any symptoms of memory loss but are at risk for developing it.
Clinical trials, currently enrolling
For more information about our current trials and research participation opportunities at the Layton Center, please contact our research team at 503-494-7647 or email@example.com.
Tele-Savvy Clinical Trial: Dementia Caregiver Research Participants Needed
The Tele-Savvy study tests the efficacy of an on-line education program for family caregivers of persons diagnosed and living with Alzheimer's disease or another dementia. Caregivers will participate in study-related video conferences, watch educational videos and complete related online interviews. Compensation will be available.
Interested caregivers can contact OHSU Site Coordinator Natasha Spoden at 503-494-6370 or firstname.lastname@example.org.
These studies follow participant health over time and are designed to increase understanding of risk factors for age related problems such as memory loss.
African American Dementia and Aging Project (AADAPt)
The overall goal of the AADAPt is to improve our understanding of age related memory loss in African Americans.
Contact Andre Pruitt, 503-494-2367 or email@example.com.
The Sharing History through Active Reminiscence and Photo-imagery (SHARP)
This study is a walking program for African Americans aged 55 or older. Participants engage in community memory building while walking through historically Black neighborhoods in North and Northeast Portland.
Contact Dr. Raina Croff at 503-494-2367 or firstname.lastname@example.org.
Oregon Brain Aging Study (OBAS)
OBAS focuses on identifying factors that protect individuals from developing dementia in later life and promote a maximal cognitive health span. OBAS is the only study in the U.S. that specifically focuses on the brain of the healthy oldest old, individuals 85 years or older. We are no longer enrolling new people into this study.